Point of care diagnosis is a process of diagnosing the abnormal condition of the body at the point of care facility (Hospital, Physicians office laboratories, Primary clinics) that gives immediate results. Point of care diagnostic has covered blood glucose testing, drug abuse screening, blood gas and electrolytes analysis, etc. The global market for point of care testing accounted to approximately $5.3 billion which is expected to grow at 7.7%. Increase in patient traffic at diagnostic center, and cost of diagnosis drives the market for POC diagnosis. CTK Biotech Inc., Diagnostics for All (DFA), BioVei Incorporated, DNA Medicine Institute (DMI) are a few companies engaged in medical device manufacturing, with investments in smart, handheld diagnostic devices.
Demand for chronic disease diagnosis through smart diagnostic devices challenge POC diagnostic markets. However, increase in investment for development of novel diagnostic devices should resolve this problem. This report provides intelligence about current market trends available in POC diagnosis tool. Report also provides market intelligence with strategies adopted by key market players.
The key players included in this market are Hema Diagnostic Systems (HDS), i+MED Laboratories Company Limited, InBios International, Inc., LumiQuick Diagnostics, Inc., J. Mitra & Co. Pvt Ltd, MP Biomedicals, CTK Biotech Inc., Diagnostics for All (DFA), BioVei Incorporated, DNA Medicine Institute (DMI)
KEY MARKET SEGMENTS
BY END USERS